This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2019 Jan 3;380(1):100.

doi: 10.1056/NEJMc1813971.

Lorcaserin Safety in Overweight or Obese Patients

Erin A Bohula¹, Stephen D Wiviott¹, Benjamin M Scirica¹

Affiliations

PMID: 30601747
DOI: 10.1056/NEJMc1813971

Comment

Lorcaserin Safety in Overweight or Obese Patients

Erin A Bohula et al. N Engl J Med. 2019.

. 2019 Jan 3;380(1):100.

doi: 10.1056/NEJMc1813971.

Authors

Erin A Bohula¹, Stephen D Wiviott¹, Benjamin M Scirica¹

Affiliation

¹ Brigham and Women's Hospital, Boston, MA ebohula11@bwh.harvard.edu.

PMID: 30601747
DOI: 10.1056/NEJMc1813971

No abstract available

PubMed Disclaimer

Comment on

Lorcaserin Safety in Overweight or Obese Patients.
Vandenbussche N, Goadsby PJ. Vandenbussche N, et al. N Engl J Med. 2019 Jan 3;380(1):99. doi: 10.1056/NEJMc1813971. N Engl J Med. 2019. PMID: 30601744 No abstract available.
Lorcaserin Safety in Overweight or Obese Patients.
Ham SY, Shin SW. Ham SY, et al. N Engl J Med. 2019 Jan 3;380(1):99. doi: 10.1056/NEJMc1813971. N Engl J Med. 2019. PMID: 30601745 No abstract available.
Lorcaserin Safety in Overweight or Obese Patients.
Coomes EA, Haghbayan H, Zipursky JS. Coomes EA, et al. N Engl J Med. 2019 Jan 3;380(1):99-100. doi: 10.1056/NEJMc1813971. N Engl J Med. 2019. PMID: 30601746 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information